ATE475424T1 - Cellulosesulfat zur behandlung von rhinovirus- infektionen - Google Patents

Cellulosesulfat zur behandlung von rhinovirus- infektionen

Info

Publication number
ATE475424T1
ATE475424T1 AT07723804T AT07723804T ATE475424T1 AT E475424 T1 ATE475424 T1 AT E475424T1 AT 07723804 T AT07723804 T AT 07723804T AT 07723804 T AT07723804 T AT 07723804T AT E475424 T1 ATE475424 T1 AT E475424T1
Authority
AT
Austria
Prior art keywords
treatment
cellulose sulfate
rhinovirus infections
rhinovirus
polymer
Prior art date
Application number
AT07723804T
Other languages
English (en)
Inventor
Andreas Grassauer
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06450051A external-priority patent/EP1842545A1/de
Priority claimed from EP06450052A external-priority patent/EP1842546B1/de
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Application granted granted Critical
Publication of ATE475424T1 publication Critical patent/ATE475424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT07723804T 2006-04-04 2007-03-30 Cellulosesulfat zur behandlung von rhinovirus- infektionen ATE475424T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06450051A EP1842545A1 (de) 2006-04-04 2006-04-04 Entzündungshemmende Polymer
EP06450052A EP1842546B1 (de) 2006-04-04 2006-04-04 Zellulosesulfat zur Behandlung von Rhinovirus-Infektionen
PCT/EP2007/002862 WO2007112966A1 (en) 2006-04-04 2007-03-30 Cellulose sulfate for the treatment of rhinovirus infection

Publications (1)

Publication Number Publication Date
ATE475424T1 true ATE475424T1 (de) 2010-08-15

Family

ID=38325129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07723804T ATE475424T1 (de) 2006-04-04 2007-03-30 Cellulosesulfat zur behandlung von rhinovirus- infektionen

Country Status (5)

Country Link
US (2) US20090298792A1 (de)
EP (2) EP2007401A2 (de)
AT (1) ATE475424T1 (de)
DE (1) DE602007008100D1 (de)
WO (2) WO2007112968A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
WO2013006795A2 (en) 2011-07-07 2013-01-10 Humanitas International Foundation Antiviral compositions and methods of their use
WO2014147287A1 (en) 2013-03-21 2014-09-25 Jukka Seppälä Nanocrystalline cellulose (ncc) as an antiviral compound
US9480828B2 (en) * 2013-11-14 2016-11-01 Gyrus Acmi, Inc. Treatment method for the inferior turbinate

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes
US6514936B1 (en) * 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ATE184049T1 (de) * 1990-07-20 1999-09-15 Bayer Ag Multimere formen des menschlichen rhinovirus- rezeptorproteins
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6391452B1 (en) * 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
JP2000256196A (ja) * 1999-03-05 2000-09-19 Pias Arise Kk 抗炎症，抗アレルギー剤
KR100317482B1 (ko) 1999-09-10 2002-01-18 유향자 수용성 키토산을 함유한 김치 영양강화제 및 이의 사용방법
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (de) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Verwendung von Chitin-enthaltenden Produkten zur Hemmung von der Erzeugung von NO
DE60114620T2 (de) * 2000-06-30 2006-07-27 Polydex Pharmaceuticals Ltd. Verwendung von Cellulosesulfat und anderen sulfatierten Polysacchariden zur Vorbeugung und Behandlung von Papilloma-Virus-Infektionen
KR100413215B1 (ko) * 2001-02-08 2003-12-31 주식회사 자광 수용성 키토산과 목향추출물로 구성된 천연 셀 전달체
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
JP2004196748A (ja) * 2002-12-20 2004-07-15 Daiwa:Kk キトサン含有消炎鎮痛皮膚外用液剤
JPWO2004085486A1 (ja) * 2003-03-25 2006-06-29 積水化学工業株式会社 皮膚外用組成物
WO2005004882A1 (en) * 2003-07-09 2005-01-20 Monash University Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
JP2005029525A (ja) * 2003-07-09 2005-02-03 Harasawa Pharmaceutical Co Ltd シリコーンを主成分とする皮膚外用剤
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity

Also Published As

Publication number Publication date
EP2040716A1 (de) 2009-04-01
WO2007112968A2 (en) 2007-10-11
DE602007008100D1 (de) 2010-09-09
US20100160254A1 (en) 2010-06-24
US20090298792A1 (en) 2009-12-03
WO2007112968A3 (en) 2007-11-15
EP2040716B1 (de) 2010-07-28
WO2007112966A1 (en) 2007-10-11
EP2007401A2 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
HRP20110861T1 (hr) Lijek za liječenje gripe
EA200802213A1 (ru) Способы лечения заболеваний крови
BR112012010270A2 (pt) mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
EA200801997A1 (ru) Новые соединения
ECSP077360A (es) Compuestos sulfonamida
CL2007002346A1 (es) Compuestos no nucleosidicos derivados de fenoxi-fenil sustituidos, inhibidores de la transcriptasa inversa del vih; composicion farmaceutica; y su uso para tratar prevenir una infeccion vih o para tratar el sida o crs.
EA201000329A1 (ru) Циклические депсипептиды
EA200900261A1 (ru) Применение эсцина
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
CY1112443T1 (el) Νεα θεραπευτικη χρηση για τη θεραπεια των λευχαιμιων
ATE424834T1 (de) Zellulosesulfat zur behandlung von rhinovirus- infektionen
ATE501717T1 (de) Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms)
EA200870263A1 (ru) Внутривенный способ лечения вирусной инфекции
ATE456949T1 (de) Verwendung von bupropionmetaboliten zur behandlung von entzündungserkrankungen
ATE413870T1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
RU2007145646A (ru) Средство для лечения вич-инфекции

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties